Overview Pharmacokinetics and Safety of DWJ1451 in Healthy Adults Status: Enrolling by invitation Trial end date: 2021-04-02 Target enrollment: Participant gender: Summary Amlodipine, olmesartan, total ezetimibe, rosuvastatin AUCt, Cmax Phase: Phase 1 Details Lead Sponsor: Daewoong Pharmaceutical Co. LTD.